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Abstract. Genetic variation in 25 Cryptosporidium isolates was analyzed using the random amplified polymorphic
DNA (RAPD) technique. Simple reproducible polymorphisms were generated (using five primers) from Cryptospor
idium DNA that was free of contaminating bacterial DNA. The results generated by four of the five primers were
statistically correlated (P < 0.001). The combined data from three primers were used to construct a phenogram using
Jaccard's distance. Four groupings could be distinguished. Two C. serpentis isolates from snakes formed a distinct
group of their own, whereas C. parvum isolates were divided into two main groups: one containing most human
isolates and the other containing mostly domestic animals plus two remaining human isolates. Due to the sensitivity
of the RAPD technique, isolates can now be analyzed genetically, directly from fecal samples without further bio
logical amplification. This represents a significant advance on current techniques.
The sporozoan parasites of the genus Cryptosporidium
have recently been recognized as significant pathogens of
vertebrate hosts, including humans and many other mam
mals, birds, reptiles, and fish.' Most clinical infections have
been associated with acute transient diarrhea (particularly in
neonates), but persistent infections may develop causing se
vere chronic disease that may become life-threatening (par
ticularly in reptiles and immunocompromised mammals).
The parasite is considered to be the most commonly detected
enteropathogen affecting patients with acquired immunode
ficiency syndrome and there is currently no effective treat
ment available.2@
Numerous species of Cryptosporidium have been recorded
since it was first thought to be host specific,' but cross-trans
mission studies have shown that infections may be trans
mitted between different host species belonging to the same
vertebrate class but not different 5 At the present
time, only six species are regarded as valid on the basis of
differences in oocyst morphology, site of infection, and ver
tebrate class specificity: C. muris and C. parvum, which in
fect mammals; C. meleagridis and C. baileyi in birds; C.
serpentis in reptiles; and C. nasorum in fish. Recently, a
strong argument has been presented that C. wrairi from
guinea pigs is a valid and distinct species.6 The species C.
parvum appears to be the most widely distributed and is the
major cause of infections in humans and livestock.'
There is an urgent need to determine the extent and nature
of genetic diversity within Cryptosporidium isolates infect
ing humans and other mammals. Appropriate molecular
characterization procedures for doing so need to be applied
so that sources of transmission can be identified and corre
lated with clinically important parameters such as severity
of infection and drug sensitivity. A major research need is
to determine levels of genetic and antigenic heterogeneity
within Cryptosporidium and to examine its zoonotic poten
tial and the clinical significance of parasite heterogeneity.7
While few differences have been found in the morpholog
ic characteristics and developmental cycles of C. parvum
isolates from mammalian hosts,8 some evidence of isolate
(or strain) variation has been observed for several other bi
ological and molecular characters. Cryptosporidium parvum
isolates from both calves and human patients have been
found to differ in their virulence for susceptible calves.9' 0
Some variation has been detected in the protein profiles of
different mammalian, avian, and reptilian isolates examined
by polyacrylamide gel electrophoresis, two-dimensional gel
electrophoresis, and oocyst surface iodination.' â€˜â€˜@ Antigenic
differences have also been detected between different mam
malian isolates in Western blot studies using host immune
sera, rabbit antisera, and mouse monoclonal antibodies)@'6
Restriction fragment length polymorphisms have been de
tected between human and calf isolates from different geo
graphic locations,'7 and isoenzyme electrophoretic studies
have demonstrated genetic diversity both within and between
different Cryptosporidium 8 9
A major limitation of all these characterization techniques,
however, is their requirement for large amounts of parasite
material that are generally not available from clinical sam
pies. Recourse is often made to passaging isolates through
experimental animals that may inadvertently select for spe
cific genotypes present in the original isolate. While para
sites can be established and maintained in 221 routine
amplification of sufficient organisms for characterization
studies is not possible.
The advent of polymerase chain reaction (PCR)â€”based
technologies has revolutionized the molecular characteriza
tion of isolates where material has been 223 We
have applied random amplified polymorphic DNA (RAPD)
analysis to the detection of genetic variation between isolates
of Cryptosporidium. This technique uses primers of arbitrary
sequence in the PCR.2@26 Amplification using a particular
RAPD primer can reveal polymorphisms in a broad range
of species, and single base changes in the primer can gen
crate completely different reproducible patterns of polymor
phisms. No prior sequence information is required and since
the technique is PCR-based, it is very sensitive and therefore
useful when only small amounts of material are available.
Due to the nonspecificity of this technique, however, (i.e.,
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merGCCTFGCACAGAGAGACGCCCGTGTRHS25
merGCGCGGAAGCGTCGGA'flA'I1@CACCGIAR
124 merATGTACGACCAGCTCAACGAGAAGIR-l36720
merCCTCCGTCAATGCCTfCAAGR-293620
merCCGTATGGCTAATAGGTGGA*R-28l720
merGCFTGGTCTGCTCAATGTGG*T719
merGTAATACGACTCACTATAGUSP17
merGTAAAACGACGGCCAGT*[GACAJ'16
merGACAGACAGACAGACA*[GAA]515
merGAAGAAGAAGAAGAA*S
Primers sequences thatgave reproducible profiles for @
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TABLE 1
isolates of Cryptosporidium used in this study
TABLE 2
Primers tested for random amplified polymorphic DNA analysis of
Cryptosporidium
CodeHostGeographic originSource*H
IHumanPerth, Western AustraliaPMHH2HumanNarrogin,
Western AustraliaSHLH3HumanNannup,
Western AustraliaPMHH4HumanPerth,
Western AustraliaPMHHSHumanPerth,
Western AustraliaPMHH6HumanPerth,
Western AustraliaPMHH7HumanPerth,
Western AustraliaPMHH8HumanPerth,
Western AustraliaSHLH9HumanPerth,
Western AustraliaSHLHl0HumanPerth,
Western AustraliaPMHHI
IHumanPerth, Western AustraliaSHLH12HumanPerth,
Western AustraliaSHLHl3HumanHorsham,
Victoria, AustraliaCVLH14HumanPort
Lincon, South AustraliaCVLLlLamb/deerEdinburgh,
ScotlandMAHClCalfMillicent,
South AustraliaCVLC2CalfLucindale,
South AustraliaCVLC3CalfMeadows,
South AustraliaCVLC4CalfLucindale,
South AustraliaCVLCSCalfPenola,
South AustraliaCVLC6CalfWillunga,
South AustraliaCVLClCalfPenola,
South AustraliaCVLC8CalfPenola,
South AustraliaCVLSISnakeTanunda,
South AustraliaCVL52SnakeTanunda,
South AustraliaCVL
filtering through sterile gauze followed by phosphate-buf
fered saline (PBS)-ether sedimentation (ether was omitted
for snake isolates due to disruption of oocysts). All isolates
were further purified by Ficoll-density 1and
washed three times in PBS. The bacterial pellets resulting
from the Ficoll purification step were also collected and
washed for use as contamination controls. Samples were
incubated in 10% sodium hypochlorite on ice for 10 mm
and then washed again three times in PBS. The purity of
each preparation was confirmed by microscopic analysis
prior to DNA isolation.
Isolation of DNA. Oocysts were resuspended in 300 p.1
of lysis buffer (containing 50 mM EDTA, 10 mM Tris, 250
mM sucrose, and 8% Triton-X 100), subjected to three
freeze-thaw cycles, and then incubated at 56Â°Cfor 3 hr with
50 p.1 of proteinase K (10 mg/ml). The DNA was isolated
from the lysate using the Prep-A-Gene DNA purification kit
(Bio-Rad, Richmond, VA). The DNA was similarly isolated
from the bacterial pellets and included as contamination con
trols in all amplifications.
Primer selection and amplification conditions. A total
of 10 primers were tested for reproducibility and reliability,
five of which gave reproducible, clear profiles (Table 2).
These were two Giardia-specific 2Omers that were synthe
sized for other purposes (R-2936 and R-28l7), two micro
satellite primers chosen at random ([GAAI5. and [GACA]4),
and the universal sequencing primer (USP). The PCRs were
set up as previously described,33 with some modifications.
Briefly, 10â€”20ng of DNA was amplified in 20 mM Tris
HC1 (pH 7.6), 30 mM KC1, 4 mM MgCl2 200 p.M of each
deoxynucleotide triphosphate, 25 pmol of primer, 2 units of
Tth Plus (Biotech International, Perth, Western Australia),
and sterile distilled water. Reactions were performed on a
thermal reactor (Hybaid, Teddington, United Kingdom). Cy
des for the 17â€”25mers were as follows: two cycles at 94Â°C
for 5 mm, 48Â°Cfor 5 mm, and 72Â°Cfor 5 mm, followed by
35 cycles at 94Â°C for I mm, 60Â°C for 1 mm, 72Â°C for 2 mm,
and a final cycle at 72Â°Cfor 10 mm. For the shorter micro
satellite primers, stringency was decreased to one cycle at
94Â°Cfor 2 mm, 35Â°Cfor I mm, and 72Â°Cfor 2 mm, fol
lowed by 35 cycles at 94Â°Cfor 1 mm, 35Â°Cfor 1 mm, and
72Â°Cfor 2 mm, and a final cycle at 72Â°Cfor 10 mm. In all
amplifications, a bacterial lysate was included as a control.
Negative controls (no DNA) were also included in every
reaction. Amplification products were subject to electropho
a PMH = Princess Margaret Hospital, Perth, westem Australia; SHL State Health
Laboratories of westem Australia; CVL = Central vetennary Laboratories. . South Aus
tralian Department of Agriculture. South Australia; MAH = Moredun Animal Health Ltd..
Edinburgh. Scotland.
any contaminating DNA will also be amplified), analysis
cannot be performed directly on fecal samples and it requires
extensive purification of parasite material prior to analysis.
The RAPD analysis has been increasingly applied to par
asite populations and has been used to differentiate isolates
of Trichinella 27schistosomes,28 Echinococcus gran
ulosus,29 and more recently, isolates of the coccidian parasite
303@ This type of analysis has been compared with
isoenzyme characterization studies for some seven parasitic
protozoan species and RAPD markers have proven to be
reliable and suitable for constructing species phylogenies
and strain 3233The application of the RAPD
technique to Cryptosporidium is, therefore, particularly suit
able because the parasite is available only in small quanti
ties, it is refractory to routine amplification, and there is little
sequence information available.
MATERIALS AND METHODS
Collection and purification of parasite material. A total
of 25 Cryptosporidium isolates were obtained from different
mammals and reptiles (Table 1). All isolates from human
patients and calves originated from natural clinical infections
diagnosed by local laboratories. A purified isolate, originally
from a deer, that had been passaged in lambs was obtained
from the Moredun Research Institute (Edinburgh, Scotland).
The snake isolates were collected from a chronically infected
taipan (Oxyuranus scutellatus) and a common death adder
(Acanthophis antarcticus). Fecal samples from infected hosts
were stored at 4Â°Cin an equal volume of 2% potassium
dichromate solution prior to oocyst harvest.
Oocysts were partially purified from fecal material byMOLECULAR CHARACFERIZATION OF CRYPTOSPORID1UM ISOLATES
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FIGURE 1. Agarose gels stained with ethidium bromide, showing random amplified polymorphic DNA profiles generated by three different
primers ([GAAI5, R-28l7, and EGACAI4,respectively,) of 25 isolates of Cryptosporidium. Lane 1 molecular weight marker (100-basepair
ladder; Gibco-BRL, Gaithersburg, MD); 2 Li; 3 Cl; 4 C2; 5 Hl; 6 H2; 7 H3; 8 H4; 9 H5; 10 H6; 11 H7; 12 =
H8; 13 = Si; 14 = 52; 15 molecular weight marker; i6 = Ll; 17 = C3; 18 = C4; 19 = CS; 20 = C6; 21 = C7; 22 = C8; 23 = H9; 24
= H10; 25 = Hll; 26 H12; 27 = H13; 28= Hl4. kb kilobases.
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retic separation in 1.5% agarose gels stained with ethidium
bromide.
Analysis of data. Individual bands were scored as present
or absent for each isolate and the inverse of Jaccard's co
efficient was calculated from the resulting data matrices.33
Data matrices generated for each primer were compared sta
tistically.34 Phylogenetic relationships were determined by
the group-average clustering strategy or the unweighted pair
group method of analysis (UPGMA) using a modified For
tran computer program (UPGMA2).35 Phenograms were con
structed based on data from three primers (R-2817, [GAA]5,
and [GACA]4).
RESULTS
The DNA profiles were generated using five primers,
(USP, R-2936, R-2817, [GAA}5, and [GACA]4). Distance
matrices between isolates for four of the primers (R-28 17,
R-2936, [GAA]5, and [GACA]4) were highly correlated (P
< 0.00l).@@ Profiles generated using the USP primer were
not significantly correlated with any of the other four prim
cr5. Data from this primer were not included in the analysis
because it was considered at variance with the other four
primers; for example, USP was unable to differentiate be
tween snake and human isolates. Data from R-2936 was
also excluded from the analysis because a complete data
set was not available for this primer due to a shortage of
material. Profiles from three primers (R-2817, [GAA]5, and
[GACA]4) are shown in Figure 1. Combined data from
these three primers grouped the 25 isolates into four rap
demes (isolates grouped genetically using RAPD pat
terns),33 respectively.
A phenogram based on Jaccard's distance was constructed
from the RAPD data to indicate phylogenetic relationships
(Figure 2). Four major groups were evident. The reptilian
isolates were grouped separately from the mammalian iso
lates. Isolates from domestic animals were found to belong
to one group and humans to another with the exception of
two human isolates. One human isolate was grouped within
the domestic animal isolates while the other formed a dis562 MORGAN AND OThERS
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tinct group closer to the domestic group than to the human
group.
DISCUSSION
The RAPD analysis revealed at least four distinct genetic
groups among the 25 Cryptosporidium isolates from mam
mals and snakes. The snake isolates grouped together but
differed from the mammalian isolates, which supports their
classification as a separate species based on host specificity,
site of infection, parasite pathogenicity, and morphology.
The C. parvum isolates from domestic animals were grouped
together, with minor differences between the lamb and calf
isolates. Human C. parvum isolates were found to be re
markably similar to each other with the exception of three
isolates. One isolate (H2) displayed a profile very similar to
calf isolates with most primers. The isolate was from a child
living in a rural area of Western Australia. Another isolate
(Hl3) from an 18-year-old woman from Victoria, Australia
showed some differences from the other human isolates, but
was similar enough to be grouped overall with humans. The
third human isolate (Hl4), which was from a six-month-old
boy from South Australia, while sharing some similarities
with the other human isolates, was genetically distinct
enough to be grouped separately.
Previous studies have shown that RAPD profiles correlate
very well with isoenzyme analysis, at least for clones of
parasitic 3233 Isoenzyme characterization studies
kb
2.0 â€”
1.5 â€”
0.6 â€”
1 2 3 4 5 6 7 8 9 10
I I I I I I
R-2817 [GAA]5 [GACA]4
FIGURE 3. Agarose gel stained with ethidium bromide, showing
random amplified polymorphic DNA profiles generated by three dif
ferent primers (see Figure 1) on individual passages of a calf isolate
(Cl) in mice. Lane I = molecular weight marker (same as in Figure
1); lanes 2, 5, and 8 = CI, original isolate; lanes 3, 6, and 9 = Cl,
first passage; lanes 4, 7 and 10 = Cl, second passage. kb = kilo
bases.
have previously found four distinct genetic groups among
mammalian isolates; two groups confined to human patients,
one to calves and one to goats.'8 Another study also reported
differences between a single human isolate and several do
mestic animal isolates.'9
The genetic differences found between human and do
mestic isolates using RAPD and isoenzyme analysis raises
serious questions about their taxonomic status and whether
they should all be classified as the single species C. parvum.
In addition, these results suggest that isolates from domestic
animals may vary in their zoonotic potential. However, little
can be presently inferred about the epidemiologic, zoonotic,
or clinical significance of parasite genetic variation. Most C.
parvum isolates originated from diverse geographic loca
tions, including one isolate from overseas, and all were as
sociated with acute or chronic clinical disease in their re
spective hosts. Further characterization studies are now be
ing performed on a broader range of subclinical and envi
ronmental isolates from the same and different geographic
locations with a view to finding genetic markers for parasite
pathogenicity and zoonotic potential, particularly since oo
cysts are now frequently being detected in both treated and
untreated water @
Reproducible RAPD profiles were generated using be
tween 0. 1 and 1 ng of DNA, which constitutes approxi
mately 4 X lO'@ oocysts. Isoenzyme analysis required soluble
extracts of at least l0@â€”l0@ oocysts for each enzym&9 and
necessitated the in vivo amplification of the oocysts prior to
commencement of the studies. Due to the sensitivity of the
RAPD assay. genetic analysis can be performed directly on
Cryptosporidium oocysts purified from fecal samples with
out any further biological amplification. This represents a
significant advance on current techniques for analyzing ge
netic variation in this organism.
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FIGURE 2. Phenogram of Jaccard's distance among rapdemes of
Cryptosporidium, clustered by the group average (unweighted pair
group method of analysis) strategy.
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The RAPD analysis is not without problems. Due to the
nonspecificity of the technique, great care must be taken to
avoid contamination. This is particularly true when ampli
fying oocyst DNA isolated from fecal material. Standard
protocols for avoiding contamination38 are strictly observed
along with other protocols. A bacterial lysate was included
as a negative control in each reaction but in every case it
did not share bands with the Cryptosporidium DNA. Am
plification of DNA in the PCR is significantly affected by
temperature and Mg@ concentration. Recently, it has been
reported that significant qualitative differences in RAPD pro
files were observed when comparing conditions that differed
in primer and template concentrations.39 These results, how
ever, were obtained using short lOmer primers; we routinely
use longer primers in our studies (15â€”24mers),33because we
find them to be much more reliable, and therefore have not
detected this lack of reproducibility due to varying template
and primer concentrations in our research.
Reproducibility of RAPD profiles was determined by am
plifying the DNA of the various isolates with each primer
repeatedly. The intensity of some bands changed and occa
sionally faint bands disappeared or appeared but the basic
profile remained unaltered. As to the stability of RAPD pro
files over time, we are at present passaging different isolates
repeatedly through mice and analyzing each passage to de
termine if the genetic profiles remain constant over time.
Initial results from one isolate (Cl) indicate that after two
passages, the genetic profiles have remained unaltered (Fig
ure 3), and further passages are ongoing.
The need to purify oocysts from fecal material is a draw
back of the RAPD technique because extensive purification
is required to obtain preparations free of bacterial contami
nation. A method of analyzing genetic variation directly on
fecal samples without the need for such extensive purifica
tion would therefore be very useful. In this respect, a series
of RAPD fragments common to most or all isolates will be
subcloned and sequenced and specific primers constructed.
The RFLP analysis can then be conducted on the amplified
products.
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